These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10879662

  • 1. Enalapril: antiproteinuric effect in children with nephrotic syndrome.
    Lama G, Luongo I, Piscitelli A, Salsano ME.
    Clin Nephrol; 2000 Jun; 53(6):432-6. PubMed ID: 10879662
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK, Varma PP, Baliga KV.
    J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
    [Abstract] [Full Text] [Related]

  • 3. [Reduction of proteinuria by enalapril, in children with nephrotic syndrome resistant to prednisone].
    Pérez-Cortés G, Santos-Atherton D, López-Montaño E.
    Gac Med Mex; 1988 Feb; 124(9-10):371-4. PubMed ID: 2854521
    [No Abstract] [Full Text] [Related]

  • 4. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
    Kumar NS, Singh AK, Mishra RN, Prakash J.
    J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
    [Abstract] [Full Text] [Related]

  • 5. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
    Bianchini G, Letizia C, Domenici A, Scavo D.
    Drugs Exp Clin Res; 1991 Jun; 17(5):263-9. PubMed ID: 1661665
    [Abstract] [Full Text] [Related]

  • 6. Enalapril and prednisone in children with nephrotic-range proteinuria.
    Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA.
    Pediatr Nephrol; 2000 Oct; 14(12):1088-91. PubMed ID: 11045392
    [Abstract] [Full Text] [Related]

  • 7. Long-term therapy with enalapril in patients with nephrotic-range proteinuria.
    Proesmans W, Wambeke IV, Dyck MV.
    Pediatr Nephrol; 1996 Oct; 10(5):587-9. PubMed ID: 8897561
    [Abstract] [Full Text] [Related]

  • 8. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Proesmans W, Van Dyck M, Devriendt K.
    Nephrol Dial Transplant; 2009 Apr; 24(4):1335-8. PubMed ID: 19147669
    [Abstract] [Full Text] [Related]

  • 9. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z.
    Am J Physiol Renal Physiol; 2008 Mar; 294(3):F628-37. PubMed ID: 18094029
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 11. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 12. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 13. Enalapril dosage in steroid-resistant nephrotic syndrome.
    Bagga A, Mudigoudar BD, Hari P, Vasudev V.
    Pediatr Nephrol; 2004 Jan; 19(1):45-50. PubMed ID: 14648339
    [Abstract] [Full Text] [Related]

  • 14. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA, Sheremet'eva OV.
    Ter Arkh; 1994 Jan; 66(6):19-22. PubMed ID: 7940357
    [Abstract] [Full Text] [Related]

  • 15. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
    Camacho Díaz JA, Giménez Llort A, García García L, Jiménez González R.
    An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
    Garini G, Mazzi A, Allegri L, Buzio C, Borghetti A.
    Miner Electrolyte Metab; 1996 Sep; 22(1-3):123-7. PubMed ID: 8676802
    [Abstract] [Full Text] [Related]

  • 17. Enalapril treatment of proteinuria in normotensive children.
    Sasinka MA, Podracka L, Boor A, Jurkovic I, Mitro A, Kovacs L.
    Bratisl Lek Listy; 1999 Sep; 100(9):476-80. PubMed ID: 10645036
    [Abstract] [Full Text] [Related]

  • 18. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 19. Enalapril prevents fatty liver in nephrotic rats.
    Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F.
    J Nephrol; 2002 Oct; 15(4):358-67. PubMed ID: 12243364
    [Abstract] [Full Text] [Related]

  • 20. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.